3 assets in Obesity Due To Prohormone Convertase I Deficiency

Therapeutic assets addressing Obesity Due To Prohormone Convertase I Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Setmelanotide Obesity Due To Prohormone Convertase I Deficiency	Rhythm Pharmaceuticals, Inc.	P3	BB (64)
Dccr Obesity Due To Prohormone Convertase I Deficiency	Soleno Therapeutics, Inc.	P2	CCC (53)
lb54640 Obesity Due To Prohormone Convertase I Deficiency	LG Chem	P2	CCC (53)